Pharma institutes sign 17 MoUs with corporates

Image
Press Trust of India New Delhi
Last Updated : Nov 05 2015 | 6:22 PM IST
National pharmaceutical institutes have signed 17 agreements with drug firms, including Dr Reddys, Sun Pharma and Wockhardt.
Seven National Institutes for Pharmaceutical Education and Research (NIPERs) have undertaken academia-industry linkage with 17 Pharma Industries of Private and Public sector, Chemical and Fertilisers Ministry said in a statement.
"These 7 NIPERs exchanged MOUs with industry heads in the presence of President Pranab Mukherjee on November 4, 2015, as a part of Visitors conference being held now 4-6th November 2015," the statement said.
NIPERs are institutions of national importance set up under NIPER Act, 1998, on the lines of IITs. There are seven NIPERs in the country.
Among the institutes, NIPER Hyderabad signed three agreements -- one each with Dr Reddy's Labs, Bharat Biotech and NATCO. NIPER Ahemdabad inked four MoUs one each with Cadila Pharmaceuticals, Cadila Healthcare (Zyudus), Sahjanand Technologies and Johnson & Johnson, it said.
Similarly, NIPER Mohali also tied up with Sun Pharma, Wockahardt, Panacea Biotech and Medley Pharmaceuticals Ltd.
Besides these, NIPERs have also tied up with six state-run pharma firms also.
Department of Pharmaceuticals has identified that academia-industry linkage as a basic requirement for translating research into development and innovation; and also to fix accountability among educational institutions, the statement added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 05 2015 | 6:22 PM IST

Next Story